Status:
COMPLETED
Long-Term Follow-up Safety of Clonidine Micropellets
Lead Sponsor:
Sollis Therapeutics, Inc.
Conditions:
Lumbosacral Radiculopathy
Eligibility:
All Genders
18-70 years
Brief Summary
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.
Eligibility Criteria
Inclusion
- Subject who have successfully completed all STX-015-18-01 study related activities, are reconfirmed to be eligible and have signed informed consent to participate.
Exclusion
- Subjects who, in the opinion of the investigator, have demonstrated significant non-compliance with STX-015-18-01 study procedures.
- Subjects who were unblinded to their treatment in STX-015-18-01 study.
Key Trial Info
Start Date :
November 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03776318
Start Date
November 15 2018
End Date
May 31 2021
Last Update
October 6 2023
Active Locations (25)
Enter a location and click search to find clinical trials sorted by distance.
1
Sollis Clinical Study Site 36
Mobile, Alabama, United States, 36605
2
Sollis Clinical Study Site 44
Phoenix, Arizona, United States, 85053
3
Sollis Clinical Study Site 40
Tucson, Arizona, United States, 85724
4
Sollis Clinical Study Site 49
Rancho Mirage, California, United States, 92270